On Tuesday, Chevron Corporation (NYSE:CVX)’s shares inclined 1.52%, and closed at $108.54, as Chevron Canada Limited, a wholly owned partner of Chevron Corporation, maker of the Delo® brand of technologically advanced heavy duty engine oils, lubricants and coolants, recently launched in Canada a new category of heavy duty motor oil designed to address the growth of severe duty applications in on- and off-highway markets. Delo 400 SD SAE 15W-30, which first launched in the U.S., is an API CJ-4 heavy duty diesel engine oil formulated using a new Chevron patent pending technology to provide key benefits for engines with “severe duty” cycles in on- and off-highway applications.
“Whether north or south of the border, the raise in severe duty operations is due to the same factors: changing driving habits on-highway, counting shorter haul lengths, the growth in intermodal delivery, and more stop-and-go operations, while off-highway frequently cycles engines from load to no load,” said Rommel Atienza, Brand Manager Americas Marketing with Chevron Products Corporation. “In just a few months, our U.S. customers leading the deployment of Delo 400 SD SAE 15W-30 have stated benefits in downtime and engine performance. Given the range of operating conditions that heavy duty must deal with in Canada, we expect to bring the same benefits to fleets here as well.”
Chevron Corporation, through its auxiliaries, engages in the petroleum, chemicals, and power and energy operations worldwide. The corporation operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, and production of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, in addition to holds interest in a gas-to-liquids plant.
Infosys Ltd ADR (NYSE:INFY)’s shares raised 1.51%, and settled at $35.07, during the last trading session on Tuesday, as Infosys Ltd ADR (INFY), will declare the results for its fourth quarter and year ended March 31, 2015 on Friday, April 24, 2015 at 1:15 p.m. Indian Standard Time (IST) ( 3:45 a.m. US ET; 00:45 a.m. PST ; 8:45 a.m. London time; 3:45 p.m. Singapore / Hong Kong time) from its Chennai Development Center.
Infosys Limited provides business consulting, technology, engineering, and outsourcing services worldwide. Its solutions comprise business IT services comprising application development and maintenance, independent validation services, infrastructure administration, business process administration, and engineering services comprising of product engineering and life cycle solutions; and consulting and systems integration services, counting consulting, enterprise solutions, systems integration, and advanced technologies.
At the end of Tuesday’s trade, Steel Dynamics, Inc (NASDAQ:STLD)’s shares picked up 1.47%, and closed at $20.32, as Steel Dynamics, Inc (STLD), declared it intends to release first quarter 2015 financial results after market close on Monday, April 20, 2015. The teleconference is planned to start at 10:00 a.m. Eastern Time on Tuesday, April 21, 2015 and will be hosted by Mark Millett, President and CEO; and Theresa Wagler, Executive Vice President and CFO.
Steel Dynamics, Inc., together with its auxiliaries, manufactures and sells steel products, processes and sells recycled ferrous and nonferrous metals, and fabricates and sells steel joist and decking products in the United States and internationally. The corporation operates in three segments: Steel Operations, Metals Recycling and Ferrous Resources Operations, and Steel Fabrication Operations. The Steel Operations segment provides a range of sheet steel products, such as hot roll, cold roll, and coated steel products; structural steel beams and pilings to construction market; various rail products for the railroad industry; rounds, round-cornered squares, and round engineered bars; angles, plain rounds, flats, channels, and billets; and merchant beams, channels, and specialty structural steel sections.
Synta Pharmaceuticals Corp (NASDAQ:SNTA), ended its Tuesday’s trading session with 1.43% gained, and closed at $2.13, Synta Pharmaceuticals (SNTA), declared recently the closing of its underwritten public offering of 25,300,000 shares of ordinary stock, counting 3,300,000 shares sold following the full exercise of the option to purchase additional shares formerly granted to the underwriters, at a public offering price of $1.75 per share. Gross proceeds to Synta are about $44.3 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Synta.
Jefferies LLC and Cowen and Corporation, LLC acted as joint book-running managers for the offering, and JMP Securities LLC and Roth Capital Partners, LLC acted as co-managers for the offering.
Synta Pharmaceuticals Corp., a biopharmaceutical corporation, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its lead oncology drug candidate comprises ganetespib, an Hsp90 inhibitor, which is in Phase III clinical trial for the treatment of non-small cell lung cancer; in Phase II clinical trial for patients with hormone receptor positive metastatic breast cancer; in Phase I clinical trial for the treatment of HER2 positive patients with metastatic breast cancer; in Phase II/III clinical trial for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome; in Phase I/II trial of paclitaxel in combination with ganetespib in patients with platinum-resistant ovarian cancer; and in Phase I/II trial in combination with the mTOR inhibitor sirolimus in patients with refractory sarcoma.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
